Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale Chief R&D Officer sold 9,703 shares at $0.78 ($7,568)
  2. 4 Open-market sale Chief Legal Officer sold 7,221 shares at $0.78 ($5,632)
  3. 4 Open-market sale President & CEO sold 19,998 shares at $0.78 ($15,598)
  4. 4 Planned sale Director sold 30,000 shares at $0.57 ($17,100)
  5. 4 Open-market sale Chief R&D Officer sold 9,791 shares at $0.72 ($7,050)
  6. 4 Open-market sale Chief Legal Officer sold 7,543 shares at $0.72 ($5,431)
  7. 4 Open-market sale President & CEO sold 20,361 shares at $0.72 ($14,660)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale Chief R&D Officer sold 10,484 shares at $3.00 ($31,452)
  10. 4 Open-market sale Chief Legal Officer sold 8,275 shares at $3.00 ($24,825)
  11. 4 Open-market sale Chief Financial Officer sold 10,267 shares at $3.00 ($30,801)
  12. 4 Open-market sale President & CEO sold 19,635 shares at $3.00 ($58,905)
  13. 4 Open-market sale Chief R&D Officer sold 13,460 shares at $3.57 ($48,052)
  14. 4 Open-market sale Chief Legal Officer sold 8,690 shares at $3.57 ($31,023)
  15. 4 Open-market sale Chief Financial Officer sold 11,095 shares at $3.57 ($39,609)
  16. 4 Open-market sale President & CEO sold 38,014 shares at $3.57 ($135,710)
  17. 4 Open-market sale Director sold 4,198 shares at $3.16 ($13,266)
  18. 4 Open-market sale Director sold 4,198 shares at $3.16 ($13,266)
  19. 4 Open-market sale Director sold 5,100 shares at $3.19 ($16,269)
  20. 4 Grant or award Director acquired 10,200 shares (grant or award)

Page 5 of 49 · 968 filings